The third edition of Docquity Pulse Check 2024 is here! Through this survey, we learnt from 900+ doctors across Southeast Asia about their preferences when connecting with pharmaceutical companies. The top takeaway? Investing in relationships and scientific credibility is the key to winning doctor engagements.
Here’s a guide we’ve put together for medical representatives:
- Nurture relationships, with consistency and across touchpoints.
- Doctors value relationships with pharma reps – 86.7% say it’s important.
- More than 70% of doctors appreciate regular updates, whether weekly or monthly.
- Digital media, in-person meetings, and messaging apps are doctors’ most used channels for brand information, signaling the requirement for a mix of touchpoints.
- Most doctors (91.6%) prefer focused discussions on just 1-3 products at a time, allowing them to absorb information.
- Build credibility through scientific content (over opinion) and educational events.
- 72.1% of doctors rank scientific literature and research as the most useful when learning about products. Scientific evidence and efficacy significantly drive prescription decisions for 83.7% of doctors.
- Almost all doctors (98.6%) recognize the crucial role of pharma-sponsored Continuing Medical Education (CME) events for their learning.
For several years, Docquity, Southeast Asia’s largest network of healthcare professionals (HCPs), connecting three out of every four, has collected data on doctor practice habits, learning trends and communication preferences. Insights are collated based on online and offline surveys of doctors across the region and specialties. The objective is to inform a deeper understanding of healthcare needs in Southeast Asia, driving improved industry interactions and ultimately, patient outcomes.
